SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

Concord Medical Services Holdings Limited

Ordinary Shares, par value US$0.0001 per share
(Title of Class of Securities)

206277 105¹
(CUSIP Number)

December 31, 2010
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

		o     Rule 13d-1(b)
		o     Rule 13d-1(c)
		þ     Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

[Continued on following pages]

 

 

CUSIP No.		206277 105		Page		2		of		9

CUSIP No.		206277 105		Page		3		of		9

CUSIP No. 206277 105	Schedule 13G	Page 4 of 9 Pages

ITEM 1(a).		NAME OF ISSUER:

Concord Medical Services Holdings Limited (the “Issuer”)

ITEM 1(b).		ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

18/F, Tower A, Global Trade Center 36 North Third Ring Road East Dongcheng District, Beijing 100013 The People’s Republic of China

ITEM 2(a).		NAME OF PERSON FILING:

		CZY Investments Limited
		Cheng Zheng

ITEM 2(b).		ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:

For CZY Investments Limited:

P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands

For Cheng Zheng:

P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands

ITEM 2(c)		CITIZENSHIP:

		CZY Investments Limited—British Virgin Islands
		Cheng Zheng—People’s Republic of China

ITEM 2(d).		TITLE OF CLASS OF SECURITIES:

Ordinary Shares, par value US$0.0001 per share

ITEM 2(e).		CUSIP NUMBER:

206277 105

ITEM 3.		STATEMENT FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b) or (c):

Not applicable

CUSIP No. 206277 105	Schedule 13G	Page 5 of 9 Pages

ITEM 4.		OWNERSHIP.

The following information with respect to the ownership of the Ordinary Shares of the Issuer by the person filing this statement is provided as of December 31, 2010. The percentage amount is based on 142,353,532 Ordinary Shares outstanding as of December 31, 2010, as derived from the Issuer’s corporate records.

Number of shares as to which the person has:

Sole power

Shared

Shared

to dispose

power to

Sole power

power to

or to

dispose or

Amount

to vote or

vote or

direct the

to direct the

Reporting

beneficially

Percent

to direct

to direct

disposition

disposition

Person

owned:

of class:

the vote:

the vote:

of:

of:

CZY Investments Limited

8,861,525

6.2

%

8,861,525

0

8,861,525

0

Cheng Zheng

8,861,525

6.2

%

8,861,525

0

8,861,525

0

CZY Investments Limited holds 8,861,525 Ordinary Shares of the Issuer. Cheng Zheng is the sole shareholder of CZY Investments Limited.

ITEM 5.		OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following: o

ITEM 6.		OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

Not Applicable.

ITEM 7.		IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

Not Applicable.

ITEM 8.		IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

Not Applicable.

CUSIP No. 206277 105	Schedule 13G	Page 6 of 9 Pages

ITEM 9.		NOTICE OF DISSOLUTION OF GROUP.

Not Applicable.

ITEM 10.		CERTIFICATION.

Not Applicable.

CUSIP No. 206277 105	Schedule 13G	Page 7 of 9 Pages

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2011

CUSIP No. 206277 105	Schedule 13G	Page 8 of 9 Pages

EXHIBIT INDEX

Exhibit No.				Description
	99.1			Joint Filing Agreement

CUSIP No. 206277 105	Schedule 13G	Page 9 of 9 Pages

Exhibit 99.1

JOINT FILING AGREEMENT

     In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Ordinary Shares, par value $0.0001 per share, of Concord Medical Services Holdings Limited and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G.